Trademark: 97518585
Word
DYNAVAX
Status
Pending
Status Code
748
Status Date
Tuesday, February 27, 2024
Serial Number
97518585
Mark Type
5000
Filing Date
Monday, July 25, 2022
Published for Opposition
Tuesday, November 7, 2023

Trademark Owner History
Dynavax Technologies Corporation - Owner At Publication

Classifications
42 Medical, scientific, pharmaceutical, and biological research and product development consultation; medical, scientific, pharmaceutical, and biological research and product development for others; medical, scientific, pharmaceutical, biological, vaccine, and vaccine adjuvant research and development; medical testing, namely, providing medical testing services in the field of immunopharmaceuticals, vaccines and vaccine adjuvants and in the field of research relating to hepatitis, viruses and other infectious diseases, inflammatory diseases, genetic diseases, neurological diseases, autoimmune diseases, and cancer; testing for scientific research purposes, namely, pharmaceutical testing services
The mark consists of the word "DYNAVAX" in stylized lettering.
DYNA VACCINE; DYNAMIC VACCINE
Color is not claimed as a feature of the mark.

Trademark Events
Feb 27, 2024
Statement Of Use Processing Complete
Feb 2, 2024
Use Amendment Filed
Feb 24, 2024
Case Assigned To Intent To Use Paralegal
Feb 2, 2024
Teas Statement Of Use Received
Jan 2, 2024
Noa E-Mailed - Sou Required From Applicant
Nov 7, 2023
Official Gazette Publication Confirmation E-Mailed
Nov 7, 2023
Published For Opposition
Oct 18, 2023
Notification Of Notice Of Publication E-Mailed
Oct 4, 2023
Approved For Pub - Principal Register
Aug 11, 2023
Teas/Email Correspondence Entered
Aug 11, 2023
Correspondence Received In Law Office
Aug 11, 2023
Teas Response To Office Action Received
May 17, 2023
Notification Of Non-Final Action E-Mailed
May 17, 2023
Non-Final Action E-Mailed
May 17, 2023
Non-Final Action Written
May 10, 2023
Assigned To Examiner
Aug 16, 2022
New Application Office Supplied Data Entered
Jul 28, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24